Connect with us


Diabetes Patients Forced To Budget For An Increase In Insulin Prices.



Diabetes Patients Forced To Budget For An Increase In Insulin Prices.

Insulin prices have skyrocketed in the USA in the last 5 years. Mandi Patterson, a mother of two sons, named Pierce and Martin, is sadly critically subject to Type 1 Diabetes. Their life span is heavily dependent upon the availability of insulin. To add more to her miseries, the decrease was also tested positive in her husband, Roc aged 47. Miss Patterson, claims that around $1000 each month of her family’s disposable income is destined to be spent on medication, specifically insulin. 

It is clear the medication they so desperately depend on, comes at a hefty price. Around $300 to $400 spent on each member of the family alone. Such amount could have been up to around $5000 if only Miss Patterson’s employers at Costco had not provided her with an extensive health insurance program. 

Patterson says, “whole financial position of her family could be jeopardized if the family is subject to a car accident or any miss-step away”.  

Type 1 diabetes is a stage where a person’s pancreas stops producing insulin and requires several dosages a day. According to a study conducted by the Health Care Cost Institute, the cost of insulin has vastly increased. The cost of insulin per person in 2012 was $2841 which reached $5705 in 2016. Up-well health, a company situated in Salt Lake City, having business operations of home delivering medication for chronic disease, surveyed in 2018. The findings of the survey stated that people have skipped taking their insulin dosages due to the rise in cost. 

Cathy Paessun, director of the Central Ohio Diabetes Association states that the “price of insulin continues to go up and has doubled in the last 4 years. The fact that anger the most is there is no change in the creation process of the product itself.” 

Due to such rise and escalation in the prices of insulin, members of Congress, of both parties have been subject to scrutiny drawn upon them. It is essential for people with Type 1 and Type 2 diabetes, where their body does not produce insulin, availability of medication is imminent. 

Reports from the National Diabetes Statistics department of the year 2017 show that out of 30.3million residents in the U.S, Type 2 diabetes is tested positive in 95%. Healthier diet and exercise, maintained by Type 2 patients can help them in tackling the disease rather than a dependency of insulin as compared to Type 1 counterpart.

Anthony Meyer, a patient of Type 1 diabetes of 29-year-old says “As extreme as it sounds, if I go without insulin I will die.” Weekly he as to pay $540 for a single vile of insulin and that is after insurance. Meyer says that he has to carefully plan out and budget his monthly expenditures so that he could cover the cost of his medication. Myers had to live with his father until the age of 29, so he could continue his medication. 

1921, an orthopedic surgeon named Frederic Banting and a medical student from the University of Toronto named Charles Bset discovered Insulin. They later sold the insulin formula to a university for a single dollar. As the university couldn’t produce the patent in large quantities due to a lack of financial strength, they teamed up with various pharmaceutical companies from the USA and abroad. 

As of this day, there is three dominant insulin manufactures Eli Lilly, Novo Nor-disk, and Sarnoff. These manufacturers make the drug, they negotiate and set prices with the pharmacy. Later health insurance companies, hire managers to prescribe drugs for the beneficiaries. 

Manufacturers claim that the majority of the people, who consume their drugs don’t pay the list price. In the year 2009, the list price of Eli Lilly’s most commonly popular insulin was $99.65, which as of now amount to $275. Greg Kueterman, a spokesman of Eli Lilly acclaims the last time the company implemented a rise in the price of its insulin product was in May 2017.

“In the vast majority of cases, people pay far less than list price at the pharmacy,” he wrote. According to the data collected on pharmaceutical public income records, it is to be noted that since 2012 the net price of Sarnoff’s Insulin’s has declined by 25%. 

However, the average cost for patients on all avenues of private health insurance and Medicare facilities have gone up by 60%. Patients having high deductible insurance plans are subject to paying more out of their pockets.  

In addition to sky rocketing insulin prices, many people with Diabetes also have issues paying for health and life insurance.  Says Carl Babels of Diabetes 365 “many people within the diabetes community may not be able to afford the best type of insurance policies for their families, due to worrying about the continuing increased cost of insulin.  Life insurance with Diabetes is generally more expensive to begin with.  Many people may not be able to afford the right amount of coverage they need, due to the out of pocket expenses for their medications.”

The initial focus should be on what the patient is paying out of their pockets against the list price of the product. 

Officials from Novo Nor-disk claim that “a majority of the patients are more inclined towards paying the list price of their products rather than the insurance subsidies bills. With high deductible insurance policies and restrictive contractual agreements, insulin does have generally become affordable”.

The lawmakers from Ohio are looking into making insulin more affordable for the general public. A bill specifically targeting insulin pricing was presented by Senator Dr. Beth Liston, a Dublin Democrat. 

The Insulin Affordability Act, which enforces that all health plan restricts insulin price at $100 with a steady 30 days’ supply. insulin is to be restricted at a pricing of $100 with a 30 days supply. Ohio Attorney General shall be asked to give recommendations and pricing strategies subject to House Bill 357 imposed. Both of these bills have been referred to the Ohio House Health Committee. The call for a transparent pricing policy on Insulin products is adamant. 

Patterson’s sister in law Meghan Carter died in 2014 to the reason of rationing in her medical treatment. She was diagnosed with Type 1 diabetics in 2011, a severe condition is known as acidosis. Her blood sugar got too high leading to the body’s blood becomes acidic. Patterson says “at that point she was starting to ration off and on”.

In the year 2018, Carter lost her job and with that her health insurance. She was forced to pay around $900 for vials of insulin that lasted max about a week. Unexpectedly on Christmas eve, Carter suddenly started vomiting, a commonly known symptom found in diabetic Acidosis patients. When her roommates returned home, they assumed Carter was fast asleep. The next morning, they were hit with the tragic news of Carter’s death when they found her on the same couch last time, they saw her. Carter died to an atrocious death; her gifts were still left unpacked under her Christmas tree. 

Patterson says when Carter’s family came to clean up the apartment they came across an empty vile of insulin and another that was barely even used leading to believe that she was rationing it for long term perspective.

From that day onward, Patterson took an oath to herself that she will do whatever in her power to fix this problem before someone else lose their life.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *